FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
The FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are
Read MoreThe FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are
Read MoreWhile weight loss drugmakers are catching a bid with investors, experts are less certain that ETFs linked to the category
Read MoreThese are the stocks posting the largest moves in early trading. Source link
Read MoreAmazon Pharmacy second online pharmacy to partner with Eli Lilly's site, and could provide faster deliveries for certain patients. Source
Read MoreWhen stocks are in steep uptrends, it can difficult be difficult to determine when a meaningful corrective move is going
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThe FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer's treatment's
Read MoreNovo Nordisk shares climbed 5% on Thursday morning after the Danish pharmaceutical giant reported positive early trial data for a
Read MoreSome Wall Street analysts said Viking's experimental obesity treatment may be "best-in-class" following the release of midstage trial data. Source
Read More